TrialBMJ open diabetes research & care2022

Efficacy and safety of the combined metabolic medication, containing inosine, nicotinamide, riboflavin and succinic acid, for the treatment of diabetic neuropathy: a multicenter randomized, double-blind, placebo-controlled parallel group clinical trial (CYLINDER).

Tatiana Kharitonova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.